violacein has been researched along with Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diks, SH; Duran, N; Ferreira, CV; Fuhler, GM; Justo, GZ; Milani, R; Peppelenbosch, MP; Queiroz, KC; Ruela-de-Sousa, RR; Spek, CA; Zambuzzi, WF | 1 |
Justo, GZ; Miranda, A; Nogueira-Pedro, A; Paredes-Gamero, EJ | 1 |
1 review(s) available for violacein and Leukemia
Article | Year |
---|---|
Hematopoietic modulators as potential agents for the treatment of leukemia.
Topics: Antimicrobial Cationic Peptides; Biological Factors; Depsipeptides; Free Radicals; Hematopoiesis; Hematopoietic System; Humans; Indoles; Leukemia; Receptors, Purinergic P2; Shikimic Acid; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2013 |
1 other study(ies) available for violacein and Leukemia
Article | Year |
---|---|
Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Calcium-Calmodulin-Dependent Protein Kinases; Calpain; Cell Death; Cell Line, Tumor; Cell Survival; Cyclic AMP-Dependent Protein Kinases; Death-Associated Protein Kinases; Endoplasmic Reticulum Stress; Golgi Apparatus; Humans; Indoles; Leukemia; Proto-Oncogene Proteins c-akt | 2012 |